FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for ADMELOG (insulin lispro) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Admelog (insulin lispro)

Snippet

SUPPL AP for ADMELOG (INSULIN LISPRO)